{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:47:54Z","timestamp":1768715274592,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ijom.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T14:31:56Z","timestamp":1363703516000},"page":"1134-1139","source":"Crossref","is-referenced-by-count":21,"title":["The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"\u00c7ankaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"\u00c7izmeci \u015eenel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kadioglu Duman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Muci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.H.","family":"Dayisoylu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Balaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2013.02.008_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ijom.2013.02.008_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Kwan Tat","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ijom.2013.02.008_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijom.2013.02.008_bib0020","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.ijom.2013.02.008_bib0025","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijom.2013.02.008_bib0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D","article-title":"Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases","volume":"92","author":"Hofbauer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijom.2013.02.008_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL\u2013RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ijom.2013.02.008_bib0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-9-26","article-title":"Therapeutic implications of osteoprotegerin","volume":"9","author":"Fili","year":"2009","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ijom.2013.02.008_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tripleo.2009.10.011","article-title":"Jaw bone changes in rats after treatment with zoledronate and pamidronate","volume":"109","author":"Senel","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2013.02.008_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2013.02.008_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijom.2012.03.026","article-title":"Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells","volume":"42","author":"Bayram","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2013.02.008_bib0060","series-title":"Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention and treatment","author":"Marx","year":"2007"},{"key":"10.1016\/j.ijom.2013.02.008_bib0065","first-page":"237","article-title":"Effect of pamidronate on bone blood flow in oophorectomized rats","volume":"47","author":"Kapitola","year":"1998","journal-title":"Physiol Res"},{"key":"10.1016\/j.ijom.2013.02.008_bib0070","first-page":"101","article-title":"Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat","volume":"49","author":"Kapitola","year":"2000","journal-title":"Physiol Res"},{"key":"10.1016\/j.ijom.2013.02.008_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2013.02.008_bib0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-3-6","article-title":"A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis","volume":"3","author":"Scheper","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.ijom.2013.02.008_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","article-title":"Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro","volume":"17","author":"Walter","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2013.02.008_bib0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.mehy.2011.04.015","article-title":"Withdrawn: bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation","volume":"77","author":"Kos","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ijom.2013.02.008_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10856-005-0625-x","article-title":"Bacterial adhesion to bisphosphonate coated hydroxyapatite","volume":"16","author":"Ganguli","year":"2005","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.ijom.2013.02.008_bib0100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/648075","article-title":"Bisphosphonate-related osteonecrosis of the jaw: the role of Actinomyces","volume":"49","author":"Naik","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijom.2013.02.008_bib0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","article-title":"Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene","volume":"67","author":"Lehrer","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2013.02.008_bib0110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0714.2010.01004.x","article-title":"Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws","volume":"40","author":"Arduino","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2013.02.008_bib0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1601-0825.2009.01568.x","article-title":"Bisphosphonate-related osteonecrosis: genetic and acquired risk factors","volume":"15","author":"Sarasquete","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2013.02.008_bib0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijom.2013.02.008_bib0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bone.2004.11.004","article-title":"Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment","volume":"36","author":"Mossetti","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2013.02.008_bib0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jcb.22676","article-title":"The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate","volume":"111","author":"Fernandez","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ijom.2013.02.008_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2004.12.145","article-title":"Nitrogen-containing bisphosphonate, YM529\/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2","volume":"328","author":"Nishida","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijom.2013.02.008_bib0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bone.2006.08.003","article-title":"Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone","volume":"40","author":"Martini","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2013.02.008_bib0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2004.19.1.147","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)","volume":"19","author":"Pan","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2013.02.008_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00784-010-0477-8","article-title":"Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro","volume":"16","author":"Koch","year":"2012","journal-title":"Clin Oral Investig"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150271300074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150271300074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T22:55:40Z","timestamp":1539816940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S090150271300074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S090150271300074X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2013.02.008","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}